Online drug prescription companies are celebrating DEAHQ's delay of a proposed rule to roll back coronavirus-era telehealth prescription flexibility. The rule would restrict the ability of doctors virtually to prescribe medications.
The DEA's proposed rule would restrict the ability of doctors virtually to prescribe medications such as Adderall and opioids, requiring in-person doctor's visits for controlled substances. However, after receiving 38,000 comments from the public, DEA Administrator Anne Milgram decided to delay the rule.
"As the mental health crisis in America continues to worsen — with nearly 1 in 4 adults suffering from mental illness in the past year and less than 50% receiving treatment — the federal government must expand access to clinically-appropriate treatments and commit to supporting telehealth so that individuals suffering from depression, anxiety, and other conditions can access evidence-based treatment options, like ketamine therapy, that work well for them," Mindbloom general counsel...
Online prescribers and telehealth advocates have been critical of the move, citing the restriction's effect on drugs such as buprenorphine, which is often prescribed to help with opioid addiction, and online psychiatry.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Michigan men fly to Chicago airport with 44 pounds of fentanyl in checked bags: DEATwo men were arrested at Midway Airport on Tuesday after they were caught with 44 pounds of fentanyl in their check bags, officials say.
Read more »
2 men arrested at Midway International Airport for trafficking 44 pounds of Fentanyl, DEA saysThe suspects granted a consensual search of their luggage, where 10 kilograms of Fentanyl were found in each bag, the DEA said.
Read more »
Eli Lilly says experimental drug slows Alzheimer’sDonanemab also comes a risk of side effects that caused the deaths of two trial participants, and a third also died after a serious case.
Read more »
Lilly to seek FDA approval for Alzheimer’s drug that firm says slows declinePharmaceutical giant Eli Lilly said it would seek FDA approval as soon as possible for an experimental drug to slow the ravages of Alzheimer’s disease after a late-stage trial showed the medication slowed cognitive decline by more than a third.
Read more »
Eli Lilly says experimental drug slows Alzheimer’s worseningEli Lilly and Co. says its experimental Alzheimer’s drug appears to slow worsening of the mind-robbing disease. The company announced preliminary findings Wednesday from a study of people in …
Read more »